nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisolone—hematologic cancer—muscle cancer	0.807	1	CtDrD
Prednisolone—SLCO1A2—Methotrexate—muscle cancer	0.0381	0.263	CbGbCtD
Prednisolone—ABCB1—Dactinomycin—muscle cancer	0.0276	0.19	CbGbCtD
Prednisolone—ABCB1—Vincristine—muscle cancer	0.017	0.117	CbGbCtD
Prednisolone—ABCB1—Etoposide—muscle cancer	0.0156	0.107	CbGbCtD
Prednisolone—ABCB1—Doxorubicin—muscle cancer	0.0106	0.0732	CbGbCtD
Prednisolone—ABCB1—Methotrexate—muscle cancer	0.0103	0.071	CbGbCtD
Prednisolone—CYP3A4—Vincristine—muscle cancer	0.0102	0.0702	CbGbCtD
Prednisolone—CYP3A4—Etoposide—muscle cancer	0.00933	0.0643	CbGbCtD
Prednisolone—CYP3A4—Doxorubicin—muscle cancer	0.00636	0.0439	CbGbCtD
Prednisolone—Aseptic necrosis—Methotrexate—muscle cancer	0.00238	0.0516	CcSEcCtD
Prednisolone—Paraplegia—Methotrexate—muscle cancer	0.00203	0.0439	CcSEcCtD
Prednisolone—Diplegia—Methotrexate—muscle cancer	0.00189	0.041	CcSEcCtD
Prednisolone—Monoplegia—Methotrexate—muscle cancer	0.00177	0.0384	CcSEcCtD
Prednisolone—Arachnoiditis—Methotrexate—muscle cancer	0.0015	0.0325	CcSEcCtD
Prednisolone—Hepatomegaly—Dactinomycin—muscle cancer	0.000893	0.0194	CcSEcCtD
Prednisolone—Neuritis—Vincristine—muscle cancer	0.000757	0.0164	CcSEcCtD
Prednisolone—Thromboembolism—Doxorubicin—muscle cancer	0.000746	0.0162	CcSEcCtD
Prednisolone—Optic neuritis—Etoposide—muscle cancer	0.000744	0.0161	CcSEcCtD
Prednisolone—Osteonecrosis—Methotrexate—muscle cancer	0.000736	0.016	CcSEcCtD
Prednisolone—Cardiomegaly—Doxorubicin—muscle cancer	0.000651	0.0141	CcSEcCtD
Prednisolone—Leukoderma—Methotrexate—muscle cancer	0.000645	0.014	CcSEcCtD
Prednisolone—Impaired healing—Methotrexate—muscle cancer	0.000634	0.0137	CcSEcCtD
Prednisolone—Leukoderma—Doxorubicin—muscle cancer	0.000558	0.0121	CcSEcCtD
Prednisolone—Neuropathy—Vincristine—muscle cancer	0.00053	0.0115	CcSEcCtD
Prednisolone—Osteoporosis—Methotrexate—muscle cancer	0.000489	0.0106	CcSEcCtD
Prednisolone—Embolism venous—Doxorubicin—muscle cancer	0.00047	0.0102	CcSEcCtD
Prednisolone—Hypernatraemia—Doxorubicin—muscle cancer	0.000451	0.00979	CcSEcCtD
Prednisolone—Neuropathy—Etoposide—muscle cancer	0.00043	0.00932	CcSEcCtD
Prednisolone—Embolism—Methotrexate—muscle cancer	0.000427	0.00926	CcSEcCtD
Prednisolone—Cardiac arrest—Vincristine—muscle cancer	0.00039	0.00846	CcSEcCtD
Prednisolone—Optic neuritis—Doxorubicin—muscle cancer	0.000386	0.00837	CcSEcCtD
Prednisolone—Embolism—Doxorubicin—muscle cancer	0.00037	0.00802	CcSEcCtD
Prednisolone—Cardiac failure congestive—Etoposide—muscle cancer	0.000366	0.00794	CcSEcCtD
Prednisolone—Keratitis—Doxorubicin—muscle cancer	0.000366	0.00794	CcSEcCtD
Prednisolone—Muscular weakness—Vincristine—muscle cancer	0.000362	0.00784	CcSEcCtD
Prednisolone—Abscess—Methotrexate—muscle cancer	0.000346	0.00751	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Etoposide—muscle cancer	0.000343	0.00744	CcSEcCtD
Prednisolone—Hepatomegaly—Doxorubicin—muscle cancer	0.000335	0.00727	CcSEcCtD
Prednisolone—Petechiae—Methotrexate—muscle cancer	0.000333	0.00723	CcSEcCtD
Prednisolone—Blister—Doxorubicin—muscle cancer	0.000329	0.00714	CcSEcCtD
Prednisolone—Dermatitis atopic—Doxorubicin—muscle cancer	0.000321	0.00695	CcSEcCtD
Prednisolone—Neuritis—Doxorubicin—muscle cancer	0.000318	0.00689	CcSEcCtD
Prednisolone—Cardiac arrest—Etoposide—muscle cancer	0.000316	0.00685	CcSEcCtD
Prednisolone—Acute coronary syndrome—Vincristine—muscle cancer	0.000312	0.00676	CcSEcCtD
Prednisolone—Myocardial infarction—Vincristine—muscle cancer	0.00031	0.00672	CcSEcCtD
Prednisolone—Neuropathy peripheral—Vincristine—muscle cancer	0.00031	0.00672	CcSEcCtD
Prednisolone—Abscess—Doxorubicin—muscle cancer	0.0003	0.00651	CcSEcCtD
Prednisolone—Herpes simplex—Methotrexate—muscle cancer	0.000297	0.00645	CcSEcCtD
Prednisolone—Stinging—Doxorubicin—muscle cancer	0.000293	0.00635	CcSEcCtD
Prednisolone—Petechiae—Doxorubicin—muscle cancer	0.000288	0.00626	CcSEcCtD
Prednisolone—Vasculitis—Methotrexate—muscle cancer	0.000281	0.00609	CcSEcCtD
Prednisolone—Sweating increased—Etoposide—muscle cancer	0.00028	0.00607	CcSEcCtD
Prednisolone—Erythema—Dactinomycin—muscle cancer	0.000276	0.00599	CcSEcCtD
Prednisolone—Viral infection—Doxorubicin—muscle cancer	0.000263	0.0057	CcSEcCtD
Prednisolone—Arthropathy—Doxorubicin—muscle cancer	0.000261	0.00566	CcSEcCtD
Prednisolone—Herpes simplex—Doxorubicin—muscle cancer	0.000258	0.00559	CcSEcCtD
Prednisolone—Ill-defined disorder—Dactinomycin—muscle cancer	0.000256	0.00556	CcSEcCtD
Prednisolone—Acute coronary syndrome—Etoposide—muscle cancer	0.000252	0.00547	CcSEcCtD
Prednisolone—Neuropathy peripheral—Etoposide—muscle cancer	0.000251	0.00544	CcSEcCtD
Prednisolone—Myocardial infarction—Etoposide—muscle cancer	0.000251	0.00544	CcSEcCtD
Prednisolone—Malaise—Dactinomycin—muscle cancer	0.000249	0.00541	CcSEcCtD
Prednisolone—Ecchymosis—Methotrexate—muscle cancer	0.000248	0.00537	CcSEcCtD
Prednisolone—Pulmonary oedema—Methotrexate—muscle cancer	0.000244	0.00529	CcSEcCtD
Prednisolone—Hiccups—Doxorubicin—muscle cancer	0.000237	0.00515	CcSEcCtD
Prednisolone—Discomfort—Dactinomycin—muscle cancer	0.000232	0.00504	CcSEcCtD
Prednisolone—Thrombophlebitis—Methotrexate—muscle cancer	0.00023	0.00498	CcSEcCtD
Prednisolone—Diabetes mellitus—Methotrexate—muscle cancer	0.000229	0.00496	CcSEcCtD
Prednisolone—Oedema—Dactinomycin—muscle cancer	0.000226	0.00489	CcSEcCtD
Prednisolone—Fluid retention—Doxorubicin—muscle cancer	0.000225	0.00489	CcSEcCtD
Prednisolone—Neuropathy—Doxorubicin—muscle cancer	0.000223	0.00483	CcSEcCtD
Prednisolone—Vertigo—Vincristine—muscle cancer	0.000222	0.00481	CcSEcCtD
Prednisolone—Ecchymosis—Doxorubicin—muscle cancer	0.000215	0.00465	CcSEcCtD
Prednisolone—Convulsion—Vincristine—muscle cancer	0.000214	0.00464	CcSEcCtD
Prednisolone—Hypertension—Vincristine—muscle cancer	0.000213	0.00462	CcSEcCtD
Prednisolone—Pulmonary oedema—Doxorubicin—muscle cancer	0.000211	0.00458	CcSEcCtD
Prednisolone—Visual disturbance—Methotrexate—muscle cancer	0.00021	0.00455	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000206	0.00446	CcSEcCtD
Prednisolone—Oedema—Vincristine—muscle cancer	0.000202	0.00437	CcSEcCtD
Prednisolone—Anaphylactic shock—Vincristine—muscle cancer	0.000202	0.00437	CcSEcCtD
Prednisolone—Thrombophlebitis—Doxorubicin—muscle cancer	0.000199	0.00432	CcSEcCtD
Prednisolone—Osteoarthritis—Methotrexate—muscle cancer	0.000199	0.00432	CcSEcCtD
Prednisolone—Diabetes mellitus—Doxorubicin—muscle cancer	0.000198	0.0043	CcSEcCtD
Prednisolone—Hyperhidrosis—Vincristine—muscle cancer	0.000195	0.00423	CcSEcCtD
Prednisolone—Pain—Dactinomycin—muscle cancer	0.000193	0.00418	CcSEcCtD
Prednisolone—Cardiac failure congestive—Doxorubicin—muscle cancer	0.00019	0.00412	CcSEcCtD
Prednisolone—Mood swings—Methotrexate—muscle cancer	0.000188	0.00409	CcSEcCtD
Prednisolone—Feeling abnormal—Dactinomycin—muscle cancer	0.000186	0.00403	CcSEcCtD
Prednisolone—Ill-defined disorder—Etoposide—muscle cancer	0.000186	0.00403	CcSEcCtD
Prednisolone—Increased appetite—Doxorubicin—muscle cancer	0.000183	0.00398	CcSEcCtD
Prednisolone—Insomnia—Vincristine—muscle cancer	0.000182	0.00395	CcSEcCtD
Prednisolone—Paraesthesia—Vincristine—muscle cancer	0.000181	0.00392	CcSEcCtD
Prednisolone—Malaise—Etoposide—muscle cancer	0.00018	0.00391	CcSEcCtD
Prednisolone—Dermatitis bullous—Doxorubicin—muscle cancer	0.00018	0.00391	CcSEcCtD
Prednisolone—Vertigo—Etoposide—muscle cancer	0.00018	0.0039	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000178	0.00386	CcSEcCtD
Prednisolone—Loss of consciousness—Etoposide—muscle cancer	0.000176	0.00381	CcSEcCtD
Prednisolone—Convulsion—Etoposide—muscle cancer	0.000173	0.00376	CcSEcCtD
Prednisolone—Hypertension—Etoposide—muscle cancer	0.000173	0.00375	CcSEcCtD
Prednisolone—Pain—Vincristine—muscle cancer	0.000172	0.00374	CcSEcCtD
Prednisolone—Osteoarthritis—Doxorubicin—muscle cancer	0.000172	0.00374	CcSEcCtD
Prednisolone—Affect lability—Doxorubicin—muscle cancer	0.00017	0.00368	CcSEcCtD
Prednisolone—Pancreatitis—Methotrexate—muscle cancer	0.000169	0.00366	CcSEcCtD
Prednisolone—Discomfort—Etoposide—muscle cancer	0.000168	0.00365	CcSEcCtD
Prednisolone—Hypersensitivity—Dactinomycin—muscle cancer	0.000166	0.0036	CcSEcCtD
Prednisolone—Cardiac arrest—Doxorubicin—muscle cancer	0.000164	0.00355	CcSEcCtD
Prednisolone—Anaphylactic shock—Etoposide—muscle cancer	0.000163	0.00354	CcSEcCtD
Prednisolone—Mood swings—Doxorubicin—muscle cancer	0.000163	0.00354	CcSEcCtD
Prednisolone—Tachycardia—Etoposide—muscle cancer	0.000159	0.00346	CcSEcCtD
Prednisolone—Dry skin—Doxorubicin—muscle cancer	0.000158	0.00342	CcSEcCtD
Prednisolone—Hyperhidrosis—Etoposide—muscle cancer	0.000158	0.00342	CcSEcCtD
Prednisolone—SERPINA6—renal system—muscle cancer	0.000155	0.0698	CbGeAlD
Prednisolone—Muscular weakness—Doxorubicin—muscle cancer	0.000152	0.0033	CcSEcCtD
Prednisolone—Abdominal distension—Doxorubicin—muscle cancer	0.00015	0.00325	CcSEcCtD
Prednisolone—Conjunctivitis—Methotrexate—muscle cancer	0.000149	0.00323	CcSEcCtD
Prednisolone—Hypersensitivity—Vincristine—muscle cancer	0.000148	0.00322	CcSEcCtD
Prednisolone—Paraesthesia—Etoposide—muscle cancer	0.000147	0.00318	CcSEcCtD
Prednisolone—Pancreatitis—Doxorubicin—muscle cancer	0.000146	0.00317	CcSEcCtD
Prednisolone—Rash—Dactinomycin—muscle cancer	0.000142	0.00308	CcSEcCtD
Prednisolone—Pain—Etoposide—muscle cancer	0.00014	0.00303	CcSEcCtD
Prednisolone—Haemoglobin—Methotrexate—muscle cancer	0.000138	0.003	CcSEcCtD
Prednisolone—Haemorrhage—Methotrexate—muscle cancer	0.000138	0.00299	CcSEcCtD
Prednisolone—Weight increased—Doxorubicin—muscle cancer	0.000136	0.00294	CcSEcCtD
Prednisolone—Feeling abnormal—Etoposide—muscle cancer	0.000135	0.00292	CcSEcCtD
Prednisolone—Nausea—Dactinomycin—muscle cancer	0.000134	0.00291	CcSEcCtD
Prednisolone—Dizziness—Vincristine—muscle cancer	0.000133	0.00289	CcSEcCtD
Prednisolone—Visual impairment—Methotrexate—muscle cancer	0.000133	0.00288	CcSEcCtD
Prednisolone—NR3C2—smooth muscle tissue—muscle cancer	0.000132	0.0592	CbGeAlD
Prednisolone—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00013	0.00282	CcSEcCtD
Prednisolone—Urticaria—Etoposide—muscle cancer	0.00013	0.00281	CcSEcCtD
Prednisolone—Conjunctivitis—Doxorubicin—muscle cancer	0.000129	0.0028	CcSEcCtD
Prednisolone—Rash—Vincristine—muscle cancer	0.000127	0.00276	CcSEcCtD
Prednisolone—Dermatitis—Vincristine—muscle cancer	0.000127	0.00275	CcSEcCtD
Prednisolone—NR3C2—renal system—muscle cancer	0.000127	0.057	CbGeAlD
Prednisolone—Headache—Vincristine—muscle cancer	0.000126	0.00274	CcSEcCtD
Prednisolone—Bradycardia—Doxorubicin—muscle cancer	0.000121	0.00263	CcSEcCtD
Prednisolone—Hypersensitivity—Etoposide—muscle cancer	0.00012	0.00261	CcSEcCtD
Prednisolone—Erythema—Methotrexate—muscle cancer	0.00012	0.0026	CcSEcCtD
Prednisolone—Haemoglobin—Doxorubicin—muscle cancer	0.00012	0.0026	CcSEcCtD
Prednisolone—Nausea—Vincristine—muscle cancer	0.00012	0.0026	CcSEcCtD
Prednisolone—Haemorrhage—Doxorubicin—muscle cancer	0.000119	0.00258	CcSEcCtD
Prednisolone—SERPINA6—bone marrow—muscle cancer	0.000117	0.0527	CbGeAlD
Prednisolone—Visual impairment—Doxorubicin—muscle cancer	0.000115	0.00249	CcSEcCtD
Prednisolone—NR3C2—cardiac atrium—muscle cancer	0.000113	0.051	CbGeAlD
Prednisolone—Vision blurred—Methotrexate—muscle cancer	0.000113	0.00245	CcSEcCtD
Prednisolone—Ill-defined disorder—Methotrexate—muscle cancer	0.000111	0.00241	CcSEcCtD
Prednisolone—SLCO1A2—renal system—muscle cancer	0.000109	0.0488	CbGeAlD
Prednisolone—Malaise—Methotrexate—muscle cancer	0.000108	0.00234	CcSEcCtD
Prednisolone—Dizziness—Etoposide—muscle cancer	0.000108	0.00234	CcSEcCtD
Prednisolone—Vertigo—Methotrexate—muscle cancer	0.000108	0.00233	CcSEcCtD
Prednisolone—Arrhythmia—Doxorubicin—muscle cancer	0.000106	0.00231	CcSEcCtD
Prednisolone—Convulsion—Methotrexate—muscle cancer	0.000104	0.00225	CcSEcCtD
Prednisolone—SERPINA6—head—muscle cancer	0.000104	0.0467	CbGeAlD
Prednisolone—Erythema—Doxorubicin—muscle cancer	0.000104	0.00225	CcSEcCtD
Prednisolone—Rash—Etoposide—muscle cancer	0.000103	0.00223	CcSEcCtD
Prednisolone—Dermatitis—Etoposide—muscle cancer	0.000103	0.00223	CcSEcCtD
Prednisolone—Headache—Etoposide—muscle cancer	0.000102	0.00222	CcSEcCtD
Prednisolone—Discomfort—Methotrexate—muscle cancer	0.000101	0.00219	CcSEcCtD
Prednisolone—NR3C2—tendon—muscle cancer	9.89e-05	0.0445	CbGeAlD
Prednisolone—CYP2A6—vagina—muscle cancer	9.79e-05	0.044	CbGeAlD
Prednisolone—Anaphylactic shock—Methotrexate—muscle cancer	9.78e-05	0.00212	CcSEcCtD
Prednisolone—Vision blurred—Doxorubicin—muscle cancer	9.78e-05	0.00212	CcSEcCtD
Prednisolone—Nausea—Etoposide—muscle cancer	9.7e-05	0.0021	CcSEcCtD
Prednisolone—Ill-defined disorder—Doxorubicin—muscle cancer	9.63e-05	0.00209	CcSEcCtD
Prednisolone—Hyperhidrosis—Methotrexate—muscle cancer	9.45e-05	0.00205	CcSEcCtD
Prednisolone—Malaise—Doxorubicin—muscle cancer	9.36e-05	0.00203	CcSEcCtD
Prednisolone—Vertigo—Doxorubicin—muscle cancer	9.32e-05	0.00202	CcSEcCtD
Prednisolone—Syncope—Doxorubicin—muscle cancer	9.3e-05	0.00202	CcSEcCtD
Prednisolone—NR3C2—vagina—muscle cancer	9.17e-05	0.0413	CbGeAlD
Prednisolone—Loss of consciousness—Doxorubicin—muscle cancer	9.12e-05	0.00198	CcSEcCtD
Prednisolone—Convulsion—Doxorubicin—muscle cancer	8.99e-05	0.00195	CcSEcCtD
Prednisolone—NR3C1—embryo—muscle cancer	8.97e-05	0.0404	CbGeAlD
Prednisolone—Hypertension—Doxorubicin—muscle cancer	8.96e-05	0.00194	CcSEcCtD
Prednisolone—Insomnia—Methotrexate—muscle cancer	8.85e-05	0.00192	CcSEcCtD
Prednisolone—Paraesthesia—Methotrexate—muscle cancer	8.78e-05	0.0019	CcSEcCtD
Prednisolone—Discomfort—Doxorubicin—muscle cancer	8.73e-05	0.00189	CcSEcCtD
Prednisolone—NR3C2—head—muscle cancer	8.47e-05	0.0381	CbGeAlD
Prednisolone—Anaphylactic shock—Doxorubicin—muscle cancer	8.47e-05	0.00184	CcSEcCtD
Prednisolone—Oedema—Doxorubicin—muscle cancer	8.47e-05	0.00184	CcSEcCtD
Prednisolone—Pain—Methotrexate—muscle cancer	8.36e-05	0.00181	CcSEcCtD
Prednisolone—Shock—Doxorubicin—muscle cancer	8.33e-05	0.00181	CcSEcCtD
Prednisolone—Tachycardia—Doxorubicin—muscle cancer	8.26e-05	0.00179	CcSEcCtD
Prednisolone—Hyperhidrosis—Doxorubicin—muscle cancer	8.19e-05	0.00178	CcSEcCtD
Prednisolone—NR3C2—testis—muscle cancer	8.19e-05	0.0368	CbGeAlD
Prednisolone—Feeling abnormal—Methotrexate—muscle cancer	8.06e-05	0.00175	CcSEcCtD
Prednisolone—Urticaria—Methotrexate—muscle cancer	7.77e-05	0.00168	CcSEcCtD
Prednisolone—Insomnia—Doxorubicin—muscle cancer	7.66e-05	0.00166	CcSEcCtD
Prednisolone—Paraesthesia—Doxorubicin—muscle cancer	7.6e-05	0.00165	CcSEcCtD
Prednisolone—SLCO1A2—head—muscle cancer	7.26e-05	0.0327	CbGeAlD
Prednisolone—Pain—Doxorubicin—muscle cancer	7.24e-05	0.00157	CcSEcCtD
Prednisolone—Hypersensitivity—Methotrexate—muscle cancer	7.21e-05	0.00156	CcSEcCtD
Prednisolone—NR3C1—smooth muscle tissue—muscle cancer	7.06e-05	0.0317	CbGeAlD
Prednisolone—SLCO1A2—testis—muscle cancer	7.02e-05	0.0316	CbGeAlD
Prednisolone—Feeling abnormal—Doxorubicin—muscle cancer	6.98e-05	0.00151	CcSEcCtD
Prednisolone—NR3C1—renal system—muscle cancer	6.79e-05	0.0306	CbGeAlD
Prednisolone—Urticaria—Doxorubicin—muscle cancer	6.73e-05	0.00146	CcSEcCtD
Prednisolone—Dizziness—Methotrexate—muscle cancer	6.47e-05	0.0014	CcSEcCtD
Prednisolone—Hypersensitivity—Doxorubicin—muscle cancer	6.24e-05	0.00135	CcSEcCtD
Prednisolone—Rash—Methotrexate—muscle cancer	6.17e-05	0.00134	CcSEcCtD
Prednisolone—Dermatitis—Methotrexate—muscle cancer	6.16e-05	0.00134	CcSEcCtD
Prednisolone—Headache—Methotrexate—muscle cancer	6.13e-05	0.00133	CcSEcCtD
Prednisolone—NR3C1—cardiac atrium—muscle cancer	6.08e-05	0.0274	CbGeAlD
Prednisolone—Nausea—Methotrexate—muscle cancer	5.81e-05	0.00126	CcSEcCtD
Prednisolone—Dizziness—Doxorubicin—muscle cancer	5.6e-05	0.00121	CcSEcCtD
Prednisolone—Rash—Doxorubicin—muscle cancer	5.34e-05	0.00116	CcSEcCtD
Prednisolone—Dermatitis—Doxorubicin—muscle cancer	5.33e-05	0.00116	CcSEcCtD
Prednisolone—Headache—Doxorubicin—muscle cancer	5.3e-05	0.00115	CcSEcCtD
Prednisolone—NR3C1—tendon—muscle cancer	5.3e-05	0.0238	CbGeAlD
Prednisolone—CYP3A4—renal system—muscle cancer	5.14e-05	0.0231	CbGeAlD
Prednisolone—NR3C1—bone marrow—muscle cancer	5.14e-05	0.0231	CbGeAlD
Prednisolone—Nausea—Doxorubicin—muscle cancer	5.03e-05	0.00109	CcSEcCtD
Prednisolone—NR3C1—vagina—muscle cancer	4.92e-05	0.0221	CbGeAlD
Prednisolone—ABCB1—embryo—muscle cancer	4.8e-05	0.0216	CbGeAlD
Prednisolone—NR3C1—head—muscle cancer	4.54e-05	0.0204	CbGeAlD
Prednisolone—NR3C1—testis—muscle cancer	4.39e-05	0.0197	CbGeAlD
Prednisolone—ABCB1—renal system—muscle cancer	3.64e-05	0.0164	CbGeAlD
Prednisolone—ABCB1—bone marrow—muscle cancer	2.75e-05	0.0124	CbGeAlD
Prednisolone—ABCB1—vagina—muscle cancer	2.63e-05	0.0118	CbGeAlD
Prednisolone—ABCB1—head—muscle cancer	2.43e-05	0.0109	CbGeAlD
Prednisolone—ABCB1—testis—muscle cancer	2.35e-05	0.0106	CbGeAlD
